Is a complete IBO research report available?

No complete published report is available for Impact BioMedical Inc. (IBO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Impact BioMedical Inc. (IBO)

NYSEAMERICAN: IBO · USD

$0.43

-0.00 (-0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IBO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	46M
Revenue (ttm)	39K
Net income (ttm)	-12.9M
EPS (ttm)	-$0.23
Shares out	107.8M
Volume	12,800.333

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 39K
Net income (ttm): -12.9M
EPS (ttm): -$0.23
Market cap: 46M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IBO indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001834105
Company name	Impact BioMedical Inc.
Country	United States
Country code	US
Cusip	45259L205
Employees	2
Employees Change	1%
Employees Change Percent	100
Enterprise value	$48.5M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-09-16
Isin	US45259L2051
Last refreshed	2026-07-30
Market cap	$46M
Market cap category	Nano-Cap
Price	$0.43
Price currency	USD
Rev Per Employee	19,500x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	IBO
Website	https://www.impactbiomedinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.1%
EV/Sales	1,244.21x
FCF yield	-3.52%
P/B ratio	4.04x
P/S ratio	1,216.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-14,256.41%
EBITDA Margin	-11,315.38%
Gross Profit	$-385,000
Net Income	$-12.9M
Net Income Growth Years	1%
Pretax Margin	-39,630.77%
Profit Per Employee	$-6.4M
ROA	-18.68
Roa5y	-6.83
ROCE	-36.11
ROE	-119.7
Roe5y	-56.54
ROIC	-21.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.85%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x
Revenue Growth3 Y	-7.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$17.1M
Cash	$20,000
Current Assets	$377,000
Current Liabilities	$1.7M
Debt	$1.1M
Debt Equity	$0.07
Equity	$14.7M
Interest Coverage	-10.65
Liabilities	$2.4M
Long Term Assets	$16.7M
Long Term Liabilities	$688,000
Net Cash	$-1.1M
Net Cash By Market Cap	$-2.28
Net Debt Equity	$0.07
Tangible Book Value	$-5.2M
Tangible Book Value Per Share	$-0.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.22
Inventory Turnover	1.54
Net Working Capital	$-227,000
Quick ratio	0.01
Working Capital	$-1.3M
Working Capital Turnover	$-0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-392.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.83%
200-day SMA	0.53
50-day SMA	0.5
50-day SMA vs 200-day SMA	50under200
All Time High	6.17
All Time High Change	-93.09%
All Time High Date	2025-03-21
All Time Low	0.36
All Time Low Change	17.79%
All Time Low Date	2025-06-20
ATR	0.04
Beta1y	-1.05
Beta2y	2.52
Ch YTD	-15.54
High	0.45
High52	0.83
High52 Date	2026-03-05
High52ch	-48.61%
Low	0.42
Low52	0.37
Low52 Date	2026-02-17
Low52ch	15.27%
Ma50ch	-14.7%
Price vs 200-day SMA	-19.27%
RSI	37.04
RSI Monthly	34.53
RSI Weekly	42.74
Sharpe ratio	0.05x
Sortino ratio	0.19
Total Return	-392.17%
Tr YTD	-15.54
Tr1m	-9.45%
Tr1w	-0.88%
Tr3m	-35.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-5.5M
Operating margin	-14,228.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,488,054%
Float Percent	10.65%
Net Borrowing	373,000
Shares Insiders	2.78%
Shares Institutions	3.45%
Shares Out	107,821,231
Shares Qo Q	20.07%
Shares Yo Y	392.17%
Short Float	4.85%
Short Ratio	8.48
Short Shares	0.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.3M
Adjusted OCF	-3,284,000
Average Volume	38,477.45x
Bv Per Share	0.11
Ch1m	-9.45
Ch1w	-0.88
Ch1y	-37.83
Ch3m	-35.38
Ch6m	-7.46
Change	-0.81%
Change From Open	-0.81
Close	0.43
Days Gap	0
Depreciation Amortization	1,429,250
Dollar Volume	5,459.3
Earnings Date	2026-08-13
EBIT	$-5.6M
EBITDA	$-4.4M
EPS	$-0.23
F Score	2
FCF	$-1.7M
FCF EV Yield	-3.45x
FCF Per Share	$-0.02
Financing CF	373,000
Fiscal Year End	December
Founded	2,018
Income Tax	$-2.6M
Investing CF	1,000
Ipr	-85.33
Iprfo	-85.33
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	0.53
Ma150ch	-19.83%
Ma20	0.45
Ma20ch	-5.43%
Net CF	-1,298,000
Next Earnings Date	2026-08-13
Open	0.43
Optionable	No
Position In Range	29.11
Price Date	2026-07-29
Relative Volume	0.33x
Revenue	39,000x
SBC By Revenue	4,133.33x
Share Based Comp	1,612,000
Tax By Revenue	-6,615.38x
Tr6m	-7.46%
Us State	Texas
Volume	12,800.3
Z Score	0.83

Impact BioMedical Inc. (IBO)

Coverage state: Market snapshot only — no published research

Generate the first IBO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · IBO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IBO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IBO

Frequently asked questions